Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$32.4 - $68.18 $3.3 Million - $6.95 Million
102,000 Added 170.0%
162,000 $11 Million
Q2 2022

Aug 15, 2022

BUY
$22.3 - $37.39 $669,000 - $1.12 Million
30,000 Added 100.0%
60,000 $1.92 Million
Q1 2022

May 13, 2022

BUY
$25.68 - $35.59 $318,432 - $441,316
12,400 Added 70.45%
30,000 $1.04 Million
Q2 2021

Aug 16, 2021

SELL
$32.46 - $43.42 $2.67 Million - $3.58 Million
-82,400 Reduced 82.4%
17,600 $618,000
Q4 2020

Feb 16, 2021

BUY
$37.65 - $63.77 $3.2 Million - $5.42 Million
85,000 Added 566.67%
100,000 $4.33 Million
Q2 2020

Aug 14, 2020

SELL
$48.73 - $81.82 $4.14 Million - $6.95 Million
-85,000 Reduced 85.0%
15,000 $946,000
Q2 2019

Aug 13, 2019

BUY
$52.6 - $63.29 $4.21 Million - $5.06 Million
80,000 Added 400.0%
100,000 $5.26 Million
Q1 2019

May 14, 2019

BUY
$39.99 - $53.48 $799,800 - $1.07 Million
20,000 New
20,000 $1.06 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.